U.S. market Open. Closes in 17 minutes

CYTH | Cyclo Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
Revenue1.08M1.38M1.59M903.38K1.01M1.01M1.24M1.50M950.46K1.57M1.69M1.04M1.03M802.37K623.87K494.94K751.18K542.31K454.36K464.69K394.53K522.37K289.43K384.59K
Cost of Revenue3.49M138.93K156.08K66.40K75.49K105.03K132.92K198.43K124.42K272.64K426.02K139.68K273.76K114.66K110.83K99.32K118.40K125.19K66.66K78.83K45.43K84.48K34.03K99.22K
Gross Profit-2.41M1.24M1.43M836.98K931.71K906.45K1.10M1.30M826.03K1.29M1.27M905.26K758.09K687.71K513.04K395.62K632.77K417.12K387.70K385.87K349.10K437.89K255.40K285.37K
Operating Expenses17.64M16.85M15.70M9.80M8.32M5.16M4.95M4.65M3.09M1.86M837.21K730.91K832.35K699.58K713.98K542.93K439.10K350.68K500.32K664.78K263.50K240.54K279.11K575.21K
Selling, General & Admin3.46M7.82M6.52M3.68M3.44M2.44M2.63M2.65M2.23M1.55M648.45K570.98K799.60K678.64K693.33K520.06KN/AN/AN/AN/AN/AN/AN/AN/A
Research & Development14.18M9.00M9.15M6.10M4.87M2.71M2.29M1.86M658.50K94.13KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating Expenses1.19M30.50K27.54K19.95K13.98K13.95K19.77K130.95K202.01K217.52K188.76K159.93K32.75K20.94K20.65K22.87K439.10K350.68K500.32K664.78K263.50K240.54K279.11K575.21K
Operating Income-20.05M-15.61M-14.27M-8.96M-7.39M-4.27M-3.84M-3.34M-2.27M-562.31K430.10K174.35K-74.26K-11.87K-200.94K-147.31K193.67K66.45K-112.61K-278.91K85.60K197.35K-23.71K-289.84K
Other Expenses / Income-7.24K160.73K-18.52K18.53K-141.75K-377.0010.26K-881.62K-165.92K-30.37K-145.19K-75.15K-23.51K-662.007.81K-65.92K9.88K-168.28K165.15K-282.58K-15.63K-31.77K-32.83K-25.99K
Before Tax Income-20.06M-15.45M-14.29M-8.94M-7.53M-4.26M-3.83M-4.22M-2.43M-592.69K284.91K99.20K-97.77K-12.53K-193.13K-213.23K203.55K-101.83K52.54K-561.49K69.98K165.58K-56.54K-315.83K
Income Tax Expenses4.00-171.00K18.52K-18.53K141.75K11.77KN/AN/A120.00KN/A80.00K25.00KN/A25.00KN/A200.00K-450.00KN/A225.00KN/A-225.00KN/AN/A195.00K
Net Income-20.06M-15.28M-14.31M-8.92M-7.67M-4.26M-3.83M-4.22M-2.55M-592.69K204.91K74.20K-97.77K-37.53K-193.13K-413.23K653.55K-101.83K-172.46K-561.49K294.98K165.58K-113.88K-510.83K
Interest ExpensesN/A-150.45KN/AN/AN/AN/AN/A28.60K31.29K33.67K53.87K61.80K25.81K4.30KN/A1.82K10.75K11.05K13.96K12.03K22.60K30.92K35.44K28.29K
Basic Shares Outstanding16.33M8.44M6.37M1.60M1.08M817.57K720.37K633.54K562.09K505.43K371.66K366.80K358.07K337.11K287.50K235.33K179.20K148.15K120.18K72.32K50.05K47.91K43.89K37.02K
Diluted Shares Outstanding16.33M8.44M6.37M1.60M1.08M817.57K720.37K633.54K562.09K505.43K371.66K366.80K358.07K337.11K287.50K235.33K179.20K148.15K120.18K72.32K50.05K47.91K43.89K37.02K
EBITDA-20.03M-15.75M-14.23M-8.97M-7.24M-4.24M-3.82M-4.09M-2.23M-406.57K486.81K303.64K-39.21K12.72K-172.55K-188.55K238.67K-63.31K101.51K-521.70K130.39K220.69K-27.15K-261.12K
EBITDA Margin-1,860.90%-1,145.03%-897.54%-992.49%-719.16%-419.60%-308.93%-272.02%-234.73%-25.94%28.75%29.06%-3.80%1.58%-27.66%-38.10%31.77%-11.67%22.34%-112.27%33.05%42.25%-9.38%-67.90%
EBIT-20.06M-15.60M-14.29M-8.94M-7.53M-4.24M-3.83M-4.20M-2.40M-559.01K338.77K161.00K-71.96K-8.22K-193.13K-211.42K214.30K-90.78K66.50K-549.47K92.58K196.50K-78.45K-287.53K
EBIT Margin-1,863.36%-1,134.02%-900.94%-989.80%-747.87%-419.51%-309.68%-279.14%-252.52%-35.66%20.01%15.41%-6.97%-1.02%-30.96%-42.72%28.53%-16.74%14.63%-118.24%23.47%37.62%-27.10%-74.76%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙